Connect with us

News

TaraCares agrees MIMOSA™ pilots and launches Menopause Intelligence™ Maturity Index for corporates

TaraCares aims to empower employers to design individualised workplace practices

Published

on

Jyoti Sharma, founder and CEO of TaraCares

TaraCares has announced its first MIMOSA™ pilots ahead of launching Menopause Intelligence™ Maturity Index.

TaraCares Global, the developer behind the virtual menopause health literacy and workplace wellbeing platform MIMOSA™, aims to reimagine how female individuals of all ages, ethnicities and genders navigate their unique menopause journey. 

A B2B HealthTech SaaS platform, MIMOSA™  is currently available through employers.

Individuals receive user-centric validated research continually personalised to their health profile, real-time history and health trace across 29 health variables extracted from analysing large scale high-quality research on menopause funded by Innovate UK and the National Institute for Health and Care Research (NIHR). This includes physiological and psychological health alongside other life stressors. 

MIMOSA™ enables employers to transform from Menopause Friendly to Menopause Intelligent, helping them benefit from sophisticated signals on the needs and diversity of their menopausal workforce. 

This, TaraCares argues, in turn empowers employers to design individualised workplace practices and prevent costs from support built for the average menopause experience. 

 

Already available on Android and iOS in 16 countries, the platform has received positive feedback from clinicians and individual users during the private launch that witnessed a user engagement rate of 84.38 per cent in 11 countries.

In an effort to expand, TaraCares has signed the first pilot for its MIMOSA™ platform with the Hampshire and Isle of Wight (HIOW) Integrated Care Services (ICS) beginning September 2023.

Jyoti Sharma, founder and CEO of TaraCares, said: “We are addressing the menopause health crisis by disrupting the menopause market and the enterprise software employee/people experience economy with MIMOSA™, creating a new category for menopause health literacy and workplace wellbeing.” 

Hilary Todd, project director for the Hampshire and Isle of Wight ICS Employee Health and Wellbeing Programme

Hilary Todd, project director for the Hampshire and Isle of Wight ICS Employee Health and Wellbeing Programme, which delivers health and wellbeing support and services to 55,000 NHS and primary care employees, added: “No two experiences of menopause are the same, so we are excited to offer MIMOSA™ to help our people gain personalised insights that support them in understanding and managing their menopause. 

“The pilot complements our menopause programme, which is designed to help colleagues feel more confident and ultimately more empowered. We hope that the personalised insights gained make a valuable difference for our people.” 

Evidence and feedback 

In the US$4.2tn wellness market comprising personalised medicine, healthy eating, nutrition and workplace wellbeing solutions, TaraCares has been unstoppable in integrating its academic and scientific research evidence with tech and clear pathways to value through its collaboration with the Wessex Academic Health Science Network (AHSN) and the York Health Economics Consortium (YHEC).

 

The research, design and development team behind MIMOSA

Evidence and feedback is central to TaraCares’s ethos. The company has collaborated with the Academic Health Sciences Networks (AHSN) in England to stay aligned with building for the NHS and has partnered with Gemma Snell, innovation and industry programme manager at NHS Innovation Service.

“Working with Gemma Snell as the innovation lead at the Wessex AHSN has been instrumental in critical analysis to develop MIMOSA™ further; collaborating on the value proposition, arranging market insights opportunities with GPs with special interest in menopause as well as a local NHS ICB Peoples Programme,” said Sharma. 

Gemma Snell, innovation and industry programme manager at NHS Innovation Service

Snell, who has spent over 10 years working in the NHS improving clinical pathways and helping health systems to provide the best care and support to patients, added: “I have been pleased to collaborate with Jyoti to realise the potential of MIMOSA™ in supporting women and female individuals to understand and manage their unique menopause so that they can take control and keep living life to the full as they transition through it”

Wessex AHSN’s Insight team also provided expertise around designing evaluation studies, funding opportunities and bid preparations.

Sharma has spent 22 years designing and delivering large-scale people-centric organisational transformations across the Americas, Europe, Middle East and Africa. 

She was in her third year of individual differences in menopause research when she decided to found her start-up in May 2022, declining PhD offers from prestigious universities in England and Australia. 

“This felt like my life-long PhD,” Sharma explained. “I traded in the Dr title for the translation of our research with tech to deliver improved health for individuals, families, organisations and ultimately our society through this inevitable transition in a female individual’s life.”

After launching the first version of its proprietary Menopause Intelligence™ Maturity Index, Sharma and her team are now focusing on an equity seed investment round that she says will help fuel their rapid growth and expansion into the US and Canada.

MIMOSA™ is available on Android and iOS in India, England, Wales, Scotland, NorthernIreland, Vietnam, Uganda, Nigeria, Kenya, Germany, Switzerland, Austria, Netherlands, USA, UAE, SaudiArabia.

News

Apricity Fertility launches new Freeze and Share programme

The Freeze and Share programme offers a solution for women who wish to preserve their fertility

Published

on

In response to the growing demand for affordable fertility options and the pressing need for egg donors, the UK virtual fertility clinic Apricity has launched an innovative Freeze and Share programme.

The initiative is designed to make egg freezing more accessible and cost-effective while simultaneously addressing the shortage of donor eggs in the UK.

In recent years, there has been a significant increase in the number of women choosing to freeze their eggs. According to the Human Fertilisation and Embryology Authority (HFEA), the number of egg freezing cycles in the UK has surged by 81 per cent to 2022. Despite this growing trend, the high costs associated with the procedure—typically upwards of £5000—have made it unaffordable for many.

The Freeze and Share programme offers a solution for women who wish to preserve their fertility; by opting to share their eggs, they can substantially reduce the cost of egg freezing.

This act not only makes the procedure more affordable but also provides much longer for donor eggs for those that need them.

Addressing the egg donor shortage

The UK faces a shortage of egg donors, with many patients experiencing long waiting times for a donor. Current statistics reveal that one in six IVF cycles are donation cycles in the UK, yet demand far outstrips supply.

Prospective parents can wait up to two years to find a suitable donor, and for many they decide to travel abroad to places like Spain and Cyprus. This brings different considerations for patients as egg donation in other countries is regulated differently to the UK, with most egg donation being completely anonymous. 

Apricity’s new programme directly addresses this gap by encouraging egg sharing. Participants in the Freeze and Share programme can donate a portion of their eggs to be used by individuals or couples in need, thereby reducing waiting times and helping more people achieve their dreams of parenthood.

“We are incredibly proud to launch our Freeze and Share Programme, which represents a significant advancement in our fertility services,” said Mel Chacksfield, CEO of Apricity Fertility.

“This new service will not only make egg freezing more accessible and affordable to the many women who may not usually have the chance to preserve their fertility, but will also mean we can better support our families and parents that rely on donor eggs to start their families.

“Our commitment to providing personalised care through innovation in the sector continues to drive us forward, ensuring we meet the evolving needs of all our patients”

To be eligible for egg sharing, women will need to meet specific criteria such as BMI, age and ovarian reserve. They will have unlimited counselling throughout the process to ensure they are fully informed and supported from the start.

Women who choose to participate in the Freeze and Share programme will then undergo the standard egg freezing process. A portion of the retrieved eggs will be frozen for their personal use, while the remaining eggs will be donated to Apricity’s frozen egg donor bank.

This mutually beneficial arrangement ensures that participants receive significant financial relief while offering a lifeline to those in need of donor eggs.

For more information on Freeze & Share visit Apricity’s website 

Continue Reading

News

Endometriosis needs to be taken as seriously as diabetes, says report

Published

on

A new report, which called for “urgent” changes in endometriosis care, has said the condition should be taken as seriously as diabetes.

The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report examined the long-standing issues faced by women with endometriosis in the UK.

The study stated that endometriosis should be treated as a chronic condition and taken as seriously as illnesses such as diabetes and bowel disease.

Currently, endometriosis symptoms are treated as multiple isolated episodes, with symptoms often going unrecognised by healthcare practitioners as potentially being endometriosis.

The report recommended that training for healthcare professionals should be improved to recognise the symptoms of endometriosis and that patients should be asked about how the condition affects them beyond just the physical symptoms.

Professor Andrew Horne, director of the University of Edinburgh’s Centre for Reproductive Health, said: “Endometriosis is frequently treated as a series of acute episodes rather than as a continuous, chronic condition. This fragmented care model overlooks the necessity for ongoing, comprehensive management, which is crucial.

“The NCEPOD report recognises the gaps in our current approach and provides important actionable guidance to drive improvements in endometriosis care.”

Emma Cox, CEO of Endometriosis UK, said: “NCEPOD’s report clearly evidences the issues faced today by those with endometriosis, and the recommendations show how improvements can – and must – be made. Implementing these will not only reduce suffering for those with endometriosis, it will also save the NHS time and resources.

“The report comes at a perfect time; we have a new government who have committed to no longer neglect women’s health, and to prioritise women’s health as the NHS is reformed.”

Dr Katy Vincent, associate professor in the Nuffield Department of Women’s and Reproductive Health, University of Oxford, added: “Endometriosis affects all areas of life and the information collected by this enquiry starkly illustrates the challenges that those with the condition experience.

“I am particularly pleased to see that the report highlights the need for holistic, multi-disciplinary care and for a pathway that takes into account the chronic nature of the disease, as these are areas that I have long considered need improvement.”

She continued: “I hope that those who contributed their experiences to the report feel they were heard and that clinicians and policy makers can now take these findings on board to urgently improve care for this common condition.”

To receive the Femtech World newsletter, sign up here.

Continue Reading

News

Daye launches workplace app to plug gaps in female healthcare support

The service helps promote health equity in the workplace by providing vital resources to support women’s health conditions

Published

on

The award-winning UK gynaecological health company Daye has launched its new workplace app, Daye for Work.

The app can be offered to employees across the UK as a workplace benefit, providing them with much-needed access to services that are often lacking from the NHS and even private healthcare companies.

Women face a widening gap in healthcare provision, with three-quarters saying they cannot access the services they need and 84 per cent reporting not being listened to by a healthcare professional.

Health issues can have a big impact on women’s careers, with three in five women saying a female health condition has affected them in the workplace.

However, support for women’s health is often lacking in the workplace. According to Benden Health, four in ten women have heard derogatory comments about a female employee’s health in the workplace.

As a result, 42 per cent of females admit that they are uncomfortable discussing health issues with their manager.

In addition, more than two thirds of female employees (70 per cent) have found it difficult to deal with periods at work and 64 per cent have faced challenges when experiencing menopause.

Offering support to employees struggling with female health conditions can help attract and retain staff, with 70 per cent of workers willing to change jobs for women’s health benefits.

Daye for Work provides an accessible and personalised service for women and assigned female at birth (AFAB) individuals.

Through the app, employees of businesses who sign up for Daye for Work can access Daye’s Menstrual Health Programme, which provides access to period pain support, plugging a major gap in healthcare provision as it can take years to diagnose conditions linked to menstrual health, such as endometriosis and adenomyosis.

Currently, menstrual pain support is also not offered by major private healthcare providers. Yet period pain can be so severe that nearly a quarter of women (23 per cent) have taken time off work for menstrual symptoms in the last six months, with nine days of productivity per woman lost every year, according to the British Medical Journal.

In monetary terms, women can lose tens of thousands during their careers as they are forced to take time off work.

Daye for Work also offers a Gynae Health Screening Programme, where users can access specialists for gynaecological-related health issues, such as recurrent vaginal infections, which is another service lacking through the NHS and private healthcare companies.

While users can access help from leading specialists through instant virtual appointments, Daye also offers at-home diagnostic tampon tests that can detect vaginal infections and STIs such as chlamydia and gonorrhoea, and soon they will also be able to detect HPV, which is the biggest cause of cervical cancer.

Users receive clear, actionable results via the platform and have prescriptions delivered to their homes.

Daye also offers educational support programmes, including workshops and webinars covering hot topics in female health, and HR policy and internal comms support. Employees signed up through their company get 20 per cent off products on the Daye website.

Valentina Milanova, founder and CEO of Daye, said: “Gaps in women’s health provision are impacting workplaces all over the UK. Female and AFAB staff are regularly forced to take time off while struggling to access much-needed support, advice and diagnosis, hitting workplace productivity and all too often being detrimental to women’s careers.

“Daye for Work will play a vital role in plugging the gaps in female healthcare, offering services that take years to access on the NHS and aren’t available from private healthcare providers.

“Offering such tailored support is transformational for workplace culture, making staff feel valued and understood, while also helping to attract and retain talent.”

Continue Reading

Trending

Copyright © 2023 Aspect Publishing Ltd. All Rights Reserved.